Research scientists

Research within Vetoquinol

The Vetoquinol Group has a large number of scientists working in different fields such as galenics, pharmacology, microbiology, clinical trials, and identifying and assessing candidate drugs. We have veterinarians and biologists as well as pharmacists in the Group, many of whom completed their formal education with a PhD.

Over 160 employees worldwide work in our various R&D centres to develop innovative new products that respond to market needs.

Vetoquinol focuses its efforts on applied research with a view to providing our customers with medical innovation. Our areas of innovation concentrate on pets, cattle and pigs, with a very strong focus on (mainly bacterial) infectious diseases, the treatment of pain and inflammation, and fighting against external parasites that affect pets.


Research programmes, research grants and partnerships: furthering research

Throughout the world, Vetoquinol fosters partnerships, both with universities and with public and private research institutes to stimulate innovation, expand and deepen scientific knowledge, and thus make advancements in the field of animal health. For example:


* The Cimalgex Research Grant Program

In 2014, Vetoquinol set up a research grant to provide funding for research projects that focus on the treatment of pain. Specialist veterinarians, who work in universities or in private clinics, are constantly looking to further knowledge and advance veterinary medicine. In order to do this, comparative studies are needed, and these are often complex and expensive. So to support this research, Vetoquinol became a sponsor and has made a total budget of €50,000 available to this grant which will be used to further research into pain relief.

Research within Vetoquinol


* Yellow Pearl research project

Yellow Pearl is a 3-year collaborative research project between Vetoquinol and public research teams. The project addresses the core issue of antibiotic use and the effects of antibiotic use on public health: as part of the effort to reduce antibiotic use, is it possible to establish treatment protocols that limit the adverse effects of antibiotic therapies while retaining their effectiveness? Several research teams from veterinary schools and the French National Institute for Agricultural Research (INRA) have been involved in the project. The outcomes of this research will be used to improve scientific knowledge about the use of marbofloxacin in the treatment of bovine respiratory infections.


* Montreal university

In Canada, Vetoquinol is a partner of the Université de Montréal and awards the Research Excellence Prize, which is given to a member of the teaching staff to recognise his or her work in the education of graduate students in veterinary science.

Research within Vetoquinol